Status:
ENROLLING_BY_INVITATION
Individually Tailored Strategies for the Precision Prevention of Gastric Cancer and Colorectal Cancer in the Community
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Gastric Cancer
Colorectal Cancer
Eligibility:
All Genders
50-75 years
Brief Summary
Gastric cancer is a global health threat. Helicobacter pylori is now recognized as the main risk factor that initiates this process; hence, H. pylori eradication has been considered the most effective...
Detailed Description
Gastric cancer is a global health threat and contributes to more than 720,000 deaths per year. In the absence of early detection, gastric cancer is associated with a high fatality rate-the 5-year surv...
Eligibility Criteria
Inclusion
- Aged 50-75 years
- Confirmed non-gastric cancer/colorectal cancer healthy participant
- Mentally competent to be able to understand the consent form
- Able to communicate with study staff for individuals
- Agree to link the screening data to National Cancer Registry
Exclusion
- Confirmed gastric cancer/colorectal cancer healthy participant
- Status post gastrectomy
Key Trial Info
Start Date :
April 14 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2029
Estimated Enrollment :
40000 Patients enrolled
Trial Details
Trial ID
NCT03793335
Start Date
April 14 2019
End Date
December 31 2029
Last Update
December 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan